Product Description
Description
- Each film coated tablet contains: Cefpodoxime Proxetil IP eq. to Cefpodoxime 200 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg
Doses
As Directed by Physician
Indication
- Cefpodoxime Proxetil and Potassium Clavulanate Tablet is an antibiotic that is used to treat various bacterial infections such as tonsillitis, ear infections, throat infections, UROLOGY tract infections (UTIs), bronchitis, and other infections. The antibiotic works by destroying the cell walls of bacteria.
Broad-Spectrum Infection ControlThis tablet effectively targets a diverse array of bacterial infections, ensuring optimal clinical outcomes in treating respiratory, urinary, and ENT infections. Its dual-action formula augments bacterial eradication, offering healthcare providers a powerful solution for difficult or resistant infections common in hospitals.
Safe Storage, Simple HandlingMaintain the potency of Cefpodoxime Proxetil and Potassium Clavulanate Tablets by storing them away from children, in cool, dry conditions, and shielded from direct light. The medication does not require refrigeration, thus simplifying storage protocols and transportation.
FAQ's of Cefpodoxime Proxetil Potassium Clavulanate Tablet:
Q: How should Cefpodoxime Proxetil and Potassium Clavulanate Tablets be stored for best efficacy?
A: The tablets should be kept out of reach of children, stored in a cool, dry place protected from light, and must not be refrigerated. Following these guidelines helps preserve the medication's effectiveness until its 6-month expiration date.
Q: What bacterial infections can this tablet treat?
A: Cefpodoxime Proxetil and Potassium Clavulanate Tablets are indicated for bacterial infections such as tonsillitis, ear infections, throat infections, urinary tract infections (UTIs), bronchitis, and several other bacterial conditions, as determined by a healthcare professional.
Q: When is it appropriate to use this antibiotic formulation?
A: This medication is intended for use under medical supervision, predominantly in hospital environments, when a patient is diagnosed with bacterial infections that are sensitive to the combination of cefpodoxime and clavulanate.
Q: Where can this tablet be sourced or supplied in India?
A: The tablets are distributed in India through a versatile network of dealers, distributors, exporters, fabricators, importers, manufacturers, producers, retailers, service providers, suppliers, traders, and wholesalers.
Q: What is the main benefit of combining Cefpodoxime Proxetil with Potassium Clavulanate in one tablet?
A: The combination enhances antibacterial action: cefpodoxime targets and destroys bacterial cell walls, while clavulanate inhibits beta-lactamase enzymes, helping overcome bacterial resistance and increasing overall effectiveness.
Q: How should patients take this tablet for maximum benefit?
A: Follow the physician's prescribed dosage regimen strictly, swallowing the tablet with water. Never alter dosage or stop treatment early, even if symptoms resolve, to ensure complete eradication of the infection and prevent resistance.